![Xeno biosciences](/api/images/company-pic/0-2303162-company.png)
Contate-nos
Sobre companhia
Xeno Biosciences, Inc. is a biotechnology company provider of novel class of treatments for metabolic diseases. Xeno Biosciences, Inc. operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.
US
Desconhecido
Desconhecido
Empresa não verificada
Transparência de negócios
- Não verificou as informações da empresa
- Peça avaliações aos seus clientes
- Não respondeu a comentários negativos